Zobrazeno 1 - 10
of 253
pro vyhledávání: '"Alan T Hirsch"'
Autor:
Kimberly M Brayton, Alan T Hirsch, Patricia J O Brien, Andrea Cheville, Pinar Karaca-Mandic, Stanley G Rockson
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114597 (2014)
Lymphedema is a common complication of cancer therapeutics; its prevalence, treatment outcomes, and costs have been poorly defined. The objective of this study was to examine lymphedema prevalence among cancer survivors and to characterize changes in
Externí odkaz:
https://doaj.org/article/5992eb12173a46c29c853ea92d734931
Publikováno v:
Frontiers in Public Health, Vol 9 (2021)
Cardiovascular disease prevention strategies include aspirin use as a preventive measure. The internet can be used to raise public awareness, promote healthy lifestyles, and improve disease management. This pilot study describes the feasibility of an
Externí odkaz:
https://doaj.org/article/252d3c69f7c1446b9a4abce6bb22ccaf
Autor:
Judith G. Regensteiner, Alan T. Hirsch
Publikováno v:
Peripheral Arterial Disease Handbook ISBN: 9780429191497
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e7a78aadc0f5db4a30dda93c0102ed6
https://doi.org/10.1201/9780429191497-8
https://doi.org/10.1201/9780429191497-8
Autor:
Jeremy R. Van't Hof, Sue Duval, Adrienne Walts, Stephen L. Kopecky, Russell V. Luepker, Alan T. Hirsch
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 10 (2017)
BackgroundNo previous study has evaluated the impact of past US Preventive Services Task Force statements on primary prevention (PP) aspirin use in a primary care setting. The aim of this study was to evaluate temporal changes in PP aspirin use in a
Externí odkaz:
https://doaj.org/article/81d01527882545c99cfa8a857579585a
Autor:
Aozhou Wu, Josef Coresh, Elizabeth Selvin, Hirofumi Tanaka, Gerardo Heiss, Alan T. Hirsch, Bernard G. Jaar, Kunihiro Matsushita
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 1 (2017)
BackgroundEvidence regarding the association of lower extremity peripheral arterial disease with quality of life (QOL) is mainly from selected clinical populations or relatively small clinical cohorts. Thus, we investigated this association in commun
Externí odkaz:
https://doaj.org/article/38ee99b8b3af47018ffcfe5f3d69891e
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 4, Iss 12, Pp n/a-n/a (2015)
Background The U.S. Preventive Services Task Force in 2009 recommended increased aspirin use for primary prevention of cardiovascular disease (CVD) in men ages 45 to 79 years and women ages 55 to 79 years for whom benefit outweighs risk. This study e
Externí odkaz:
https://doaj.org/article/ad42bedddf404714aae3b24681e3e0fc
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 4, Iss 12, Pp n/a-n/a (2015)
Background Daily low‐dose aspirin is recommended for primary prevention of myocardial infarction and stroke in higher‐risk patients. Population trends in aspirin use for cardiovascular disease (CVD) prevention in an urban population (Minneapolis/
Externí odkaz:
https://doaj.org/article/c911af26ab2f43fea54f8c9ac69fb396
Autor:
Steven R. Bailey, Joshua A. Beckman, Timothy D. Dao, Sanjay Misra, Piotr S. Sobieszczyk, Christopher J. White, L. Samuel Wann, Timothy Dao, Herbert D. Aronow, Reza Fazel, Heather L. Gornik, Bruce H. Gray, Jonathan L. Halperin, Alan T. Hirsch, Michael R. Jaff, Venkataramu Krishnamurthy, Sahil A. Parikh, Amy B. Reed, Fadi Shamoun, Rita E. Shugart, E. Kent Yucel
Publikováno v:
Journal of the American College of Cardiology. 73:214-237
Gregory J. Dehmer, MD, MACC, MSCAI, FAHA, Co-Chair [∗∗][1] John U. Doherty, MD, FACC, Co-Chair [∗∗][1] Steven R. Bailey, MD, FACC, MSCAI, FAHA[††][2] Nicole M. Bhave, MD, FACC[∗∗][1] Alan S. Brown, MD, FACC, FSCAI, FAHA[††][2] Sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55414a66853ef282a0b9458f60f2c4fa
https://doi.org/10.1016/j.jacc.2018.10.002
https://doi.org/10.1016/j.jacc.2018.10.002
Approximately eight to twelve million individuals in the United States are affected by peripheral arterial disease (PAD). With 200 tables and illustrations and a single focus on peripheral arterial disease (PAD) rather than all vascular disorders, th